Vladimirova et al. demonstrated that secukinumab 150mg achieved for axSpA disease activity score remission by Week 16 in 35% of biologic-naïve axSpA patients in the investigator-initiated TRACE study. Find out more on the IMID Forum here: ow.ly/WAy650Z0ah1

EULAR 2026: Suspected spinal fracture in axial SpA? Think beyond X-rays. CT and/or MRI now take center stage, especially in #axSpA.

“#AxSpA patients have a high risk for #CardiovascularDisease, not only because this type of #arthritis attacks your #ImmuneSystem, but because it creates systemic #inflammation that is extremely hard on your heart.”: buff.ly/RX1b5rR by @globetrotteri

📢 @DrPoddubnyy on pregnancy, BMI and age in #axSpa diagnosis: “These factors may contribute to non-specific bone marrow edema and thereby reduce the specificity of isolated bone marrow oedema for axial spondyloarthritis.” @k_bressem vist.ly/57q5i

What b/ts DMARDs are effective and not effective in axSpA? Prof. Astrid van Tubergen presents this very informative summary slide summarizing treatment in axSpA. @RheumNow #EULAR2026

The new ASAS-SPARTAN criteria rely far more heavily on imaging than the 2009 version in #axSpA. Fewer patients are classified on clinical features alone. Abstr#0239 @RheumNow #EULAR2026

Axial spondyloarthritis (axSpA) isn't just about back pain; it's about long-term disability prevention. The ASAS criteria highlight the importance of early diagnosis, yet many still rely on old imaging techniques that miss subtle changes. The 2022 METEOR trial showed that MRI can detect inflammation far earlier than conventional X-rays, leading to timely interventions. If we're not using cutting-edge imaging, we're failing our patients. We need to shift our approach—let's start prioritizing early imaging in axSpA assessments. Your patients depend on it.

Carrie shares her story about life with D2T #axSpA in #Taiwan. She talks about her treatment-resistant arthritis. Her site #MySeveralWorlds is a patient centered hub in Asia that assists folks who are chronically ill & disabled. 🔗 arthritis.theenthusiasticlif… @rea

🎙️ Our #EULAR2026 Review Podcast is now live! Join Doctor Sofia Ramiro and Professors Laura Coates and Xenofon Baraliakos as they wrap up this year’s congress with expert reflections on the most significant updates in IMID care, including key insights into RA, PsA, and axSpA. 🎧 Listen here:ow.ly/egy050Zb1KI

Kann trotzdem ne AxSpa sein. Vielleicht sieht man es in 10-15Jahren dann im Röntgen, wenn man es jetzt nicht behandelt. (Ironie off)

HLA B27 gemacht? Negativ schließt AxSpa allerdings nicht aus

New: Classification Criteria and Recommendations in SpA ASAS and SPARTAN have updated their key classification criteria for axSpA. EULAR has also recently revised its recommendations on the role of imaging in the diagnosis and clinical management of SpA. buff.ly/0N9dbq5

🦴📖 Explore a comprehensive review of the latest advances in the treatment of axial spondyloarthritis (axSpA), covering diagnosis, disease mechanisms, and emerging targeted therapies. 📍 Department of Rheumatology, Chatzikosta General Hospital, Greece 🔗 mdpi.com/2076-3271/13/1/32

Is Your Autoimmune Medication Safe During Pregnancy? Find the answers you need to know in this week's Spondycast episode, Family Planning with Spondyloarthritis: What Partners and Fathers Need to Know. Alfred N. Romeo, BA, BSN, RN, MS, PhD , a @MotherToBaby expert, shares some eye-opening insights about family planning when spondyloarthritis is part of the picture. Listen now: spondylitis.org/podcasts/epi… #familyplanning #fertility #pregnancy #fatherhood #paternalexposure #medications #axspa #ankylosingspondylitis

I can feel it 2 days in advance thanks to Nr AxSpA

Ugh. Pharmacy cannot fulfil my prescription yet again due to shortages. My #AxSpA is flaring as no anti-TNFs currently due to the new kidney Dx. Now I can’t get meds I need for kidney. Waiting for call back from GP surgery re possible change of medication. #Spoonie

What an incredible few days at #EULAR2026! It was inspiring to listen to presentations by patient representatives during the PARE programme; encouraging to hear about the clinical developments and research taking place around the world; and rewarding to ensure the voice of the international #axSpA community was heard throughout the congress! Thank you to our Trustees and members who spoke on behalf of people living with #AxialSpondyloarthritis. Thanks to everyone who raised awareness during EULAR by wearing their orange shoelaces! #LaceUpForAxSpA @eular_org - European Alliance of Associations for Rheumatology

Our new #axSpA April publications are now live on our website: ow.ly/GoRf50Z0aeo See more on the #IMIDForum

The axSpA classification has been revised with the 2025 ASAS SPARTAN criteria. 5 abstracts at #EULAR2026 Abstr OP0236, OP0100, OP0239, POS0190 and POS1341. The single most important change in the 2025 criteria: MRI is now the highest-weighted variable and what counts as a positive MRI has been completely redefined. Bone marrow oedema alone is no longer sufficient. OP0100 #axSpA #MRI @RheumNow #EULAR2026